Phase I Study of CPI-300 in Patients With Advanced Tumors
NCT04808453
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Tumors
Interventions
DRUG:
CPI-300
Sponsor
Coordination Pharmaceuticals, Inc.